SuzanneRHaymanMD

PubMed

• 119 citations
  Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-κB signaling pathways in Waldenström's macroglobuli...
  Esteban Braggio, Jonathan J Keats, Xavier Leleu, Scott Van Wier, Victor H Jimenez-Zepeda
  Cancer Research. 2009-04-15
• 1789 citations
  Improved survival in multiple myeloma and the impact of novel therapies
  Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman
  Blood. 2008-03-01
• 52 citations
  Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
  Sutapa Sinha, Dennis A. Gastineau, Ivana N. Micallef, William J. Hogan, S. M. Ansell
  Bone Marrow Transplantation. 2011-07-01

Journal Articles

• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Comparable Outcomes Using Propylene Glycol-Free Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma  
  Morie A Gertz, Shaji K Kumar, Martha Q Lacy, Prashant Kapoor, Suzanne R Hayman, Robert C Wolf, William J Hogan, Wilson I Gonsalves, Angela A Dispenzieri, David Dingli,..., Nature
• Join now to see all

Abstracts/Posters

• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Use of Maintenance Therapy Post Autologous Stem Cell Transplantation Outside of Clinical Trial Setting for Multiple Myeloma: Single Institution Experience
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
  Suzanne Haymann, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
  Suzanne R. Hayman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018